Risk factors for breast cancer in young women by oestrogen receptor and progesterone receptor status

被引：34
|
作者：
McCredie, MRE
Dite, GS
Southey, MC
Venter, DJ
Giles, GG
Hopper, JL
机构：
[1] Univ Melbourne, Ctr Genet Epidemiol, Carlton, Vic 3053, Australia
[2] Univ Otago, Dept Prevent & Social Med, Dunedin, New Zealand
[3] Univ Melbourne, Dept Pathol, Genet Epidemiol Lab, Melbourne, Vic, Australia
[4] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia
[5] Canc Council Victoria, Canc Epidemiol Ctr, Melbourne, Vic, Australia
[6] Canc Council New S Wales, Canc Epidemiol Res Unit, Sydney, NSW, Australia
来源：
BRITISH JOURNAL OF CANCER | 2003年 / 89卷 / 09期
关键词：
breast cancer in young women; epidemiology; oestrogen and progesterone receptor status;
D O I：
10.1038/sj.bjc.6601293
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
We used data from 765 cases and 564 controls in the population-based Australian Breast Cancer Family Study to investigate whether, in women under the age of 40, the profile of risk factors differed between breast cancer subtypes defined by joint oestrogen and progesterone receptor status. As hypothesised, no significant differences were found.
引用
收藏
页码：1661 / 1663
页数：3
相关论文
共 50 条
  • [21] Oestrogen and progesterone receptor status of individual foci in multifocal invasive ductal breast cancer
    Garimellal, V.
    Long, E. D.
    O'Kane, S. L.
    Drew, P. J.
    Cawkwell, L.
    ACTA ONCOLOGICA, 2007, 46 (02) : 204 - 207
  • [22] Smoking and breast cancer risk by race/ethnicity and oestrogen and progesterone receptor status: the Multiethnic Cohort (MEC) study
    Gram, Inger T.
    Park, Song-Yi
    Maskarinec, Gertraud
    Wilkens, Lynne R.
    Haiman, Christopher A.
    Le Marchand, Loic
    INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2019, 48 (02) : 501 - 511
  • [23] MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neureceptor status in breast cancer
    Aoife J Lowery
    Nicola Miller
    Amanda Devaney
    Roisin E McNeill
    Pamela A Davoren
    Christophe Lemetre
    Vladimir Benes
    Sabine Schmidt
    Jonathon Blake
    Graham Ball
    Michael J Kerin
    Breast Cancer Research, 11
  • [24] Risk factors for postmenopausal breast cancer defined by estrogen and progesterone receptor status: The multiethnic cohort
    Setiawan, Veronica
    Monroe, Kristine
    Wilkens, Lynne
    Kolonel, Laurence
    Pike, Malcolm
    Henderson, Brian
    CANCER RESEARCH, 2008, 68 (09)
  • [25] Meta-analysis of the impact of progesterone receptor status on oncological outcomes in oestrogen receptor-positive breast cancer
    Boland, M. R.
    Ryan, E. J.
    Dunne, E.
    Aherne, T. M.
    Bhatt, N. R.
    Lowery, A. J.
    BRITISH JOURNAL OF SURGERY, 2020, 107 (01) : 33 - +
  • [26] Longterm prognostic value of oestrogen receptor and progesterone receptor in early stage breast cancer
    不详
    EJC SUPPLEMENTS, 2004, 2 (09): : 89 - 89
  • [27] Association between estrogen receptor/progesterone receptor status and risk factors in postmenopausal women with endometrioid type endometrial cancer
    Lee, Jisoo
    Lee, Eunhyun
    Choi, Minseong
    Park, Minjeong
    Ji, Yong-Il
    Kim, Su-Ji
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (SUPPL_4) : A158 - A158
  • [28] Progesterone receptor status of breast cancer metastases
    Brankovic-Magic, M
    Jankovic, R
    Neskovic-Konstantinovic, Z
    Nikolic-Vukosavljevic, D
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2002, 128 (01) : 55 - 60
  • [29] Progesterone receptor status of breast cancer metastases
    M. Branković-Magić
    R. Janković
    Z. Nešković-Konstantinović
    D. Nikolić-Vukosavljević
    Journal of Cancer Research and Clinical Oncology, 2002, 128 : 55 - 60
  • [30] Effect of neoadjuvant chemotherapy on oestrogen receptor, progesterone receptor and HER 2 receptor expression in breast cancer
    Sircar, T.
    Chaudhri, S.
    Francis, A.
    EJC SUPPLEMENTS, 2009, 7 (02): : 140 - 140
12345